Welcome to DU!
The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards.
Join the community:
Create a free account
Support DU (and get rid of ads!):
Become a Star Member
Latest Breaking News
Editorials & Other Articles
General Discussion
The DU Lounge
All Forums
Issue Forums
Culture Forums
Alliance Forums
Region Forums
Support Forums
Help & Search
General Discussion
In reply to the discussion: CNN's Sanjay Gupta: We've been misled about cannabis [View all]RainDog
(28,784 posts)115. I just know
about the work I've read that others have done on the subject.
But there are more than a few different people doing research into the benefits of psychotropics for certain mental conditions - and, again, the govt. in the U.S., and elsewhere, refuses to grant funding for much of the research. It's not just LSD that's blocked from study.
http://www.guardian.co.uk/science/2013/apr/07/magic-mushrooms-treat-depression
Trials of psilocybin blocked by drugs law red tape, says Professor David Nutt of Imperial College London
...Scientists believe the chemical psilocybin, the psychedelic ingredient in magic mushrooms, can turn down parts of the brain that are overactive in severely depressive patients. The drug appears to stop patients dwelling on themselves and their own perceived inadequacies.
However, a bid by British scientists to carry out trials of psilocybin on patients in order to assess its full medical potential has been blocked by red tape relating to Britain's strict drugs laws. Professor David Nutt, professor of neuropsychopharmacology at Imperial College London, will tell a conference today that because magic mushrooms are rated as a class-A drug, their active chemical ingredient cannot be manufactured unless a special licence is granted.
"We haven't started the study because finding companies that could manufacture the drug and who are prepared to go through the regulatory hoops to get the licence is proving very difficult," said Nutt. "The whole field is so bedevilled by primitive old-fashioned attitudes. Even if you have a good idea, you may never get it into the clinic, it seems."
Research by Nutt has found that psilocybin switches off part of the brain called the anterior cingulate cortex. It was known that this area is overactive in individuals suffering from depression. In his tests on healthy individuals, it was found that psilocybin had a profound effect on making these volunteers feel happier weeks after they had taken the drug, said Nutt who was sacked as the chairman of the Advisory Council on the Misuse of Drugs in 2009 after repeatedly clashing with government ministers about the dangers and classification of illicit drugs.
Trials of psilocybin blocked by drugs law red tape, says Professor David Nutt of Imperial College London
...Scientists believe the chemical psilocybin, the psychedelic ingredient in magic mushrooms, can turn down parts of the brain that are overactive in severely depressive patients. The drug appears to stop patients dwelling on themselves and their own perceived inadequacies.
However, a bid by British scientists to carry out trials of psilocybin on patients in order to assess its full medical potential has been blocked by red tape relating to Britain's strict drugs laws. Professor David Nutt, professor of neuropsychopharmacology at Imperial College London, will tell a conference today that because magic mushrooms are rated as a class-A drug, their active chemical ingredient cannot be manufactured unless a special licence is granted.
"We haven't started the study because finding companies that could manufacture the drug and who are prepared to go through the regulatory hoops to get the licence is proving very difficult," said Nutt. "The whole field is so bedevilled by primitive old-fashioned attitudes. Even if you have a good idea, you may never get it into the clinic, it seems."
Research by Nutt has found that psilocybin switches off part of the brain called the anterior cingulate cortex. It was known that this area is overactive in individuals suffering from depression. In his tests on healthy individuals, it was found that psilocybin had a profound effect on making these volunteers feel happier weeks after they had taken the drug, said Nutt who was sacked as the chairman of the Advisory Council on the Misuse of Drugs in 2009 after repeatedly clashing with government ministers about the dangers and classification of illicit drugs.
Edit history
Please sign in to view edit histories.
Recommendations
0 members have recommended this reply (displayed in chronological order):
132 replies
= new reply since forum marked as read
Highlight:
NoneDon't highlight anything
5 newestHighlight 5 most recent replies
RecommendedHighlight replies with 5 or more recommendations
He admits his mistake now, when it is relatively safe to do so from a public relations standpoint...
markpkessinger
Aug 2013
#102
... big pharma must be getting closer to genetic replication & Copyrighting ....
Myrina
Aug 2013
#29
how many lives have been ruined by this bullshit? how much money has been made on drug war?
spanone
Aug 2013
#32
Good for Gupta, he stopped lying! I think the seizure patients make it hard for
Bluenorthwest
Aug 2013
#35
I was having serious emotional side effects from the chronic back/neck/arm pain from
kestrel91316
Aug 2013
#52
Too much is at stake for big brother to fully decriminalize cannabis, for all that funding
indepat
Aug 2013
#54
It's helpful if you can trust him and I dont. He wanted so badly to be Surgeon General
rhett o rick
Aug 2013
#127
But think about it. "he didnt do his homework"? This man is supposed to be brilliant, and
rhett o rick
Aug 2013
#79
More like, "I realize my credibility is suffering because I'm lumped in with this other idiot."
Spitfire of ATJ
Aug 2013
#93
Their new argument- you can tell the rationale is failing- is "its very unlikely that a pot smoker
Warren DeMontague
Aug 2013
#122